TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

J.Lo to open cellphone stores

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

VZ $51.89 +$0.42

at close on THURSDAY

Daily Photo Galleries

By The Associated Press
Thursday, May 23, 2013, 9:45 p.m.
 

“Jenny from the Block” wants the block to buy Verizon phones from her.

Singer-actress Jennifer Lopez said she's opening a chain of cellphone stores and a website under the Viva Mobil brand. The aim is to sell Verizon phones and services to Latinos.

The first store will open in New York on June 15. Lopez said the stores will have bilingual staff and provide a “culturally relevant shopping experience.”

Viva Mobil will be an authorized Verizon reseller, with the same prices and plans as regular Verizon stores.

Marketing cellphone service specifically to Latinos has not been a winning formula so far in the United States. One company targeting Spanish speakers, Movida Communications, raised $40 million in 2007 and filed for bankruptcy the following year.

Subscribe today! Click here for our subscription offers.

 

 


Show commenting policy

Most-Read Business Headlines

  1. Wolf reverses Corbett, says deal between Highmark, UPMC doesn’t limit continuity of care to very ill
  2. Unemployment rate continues to drop as U.S. adds 295K jobs
  3. Apple to replace AT&T in Dow
  4. Alcoa may close or sell some aluminum plants to cut costs
  5. Toyota Mirai to run on hydrogen fuel cells, widen green-vehicle divide
  6. Race toward bigger phones eases
  7. First Niagara depositors’ money safe, bank says
  8. ‘Shark Tank’ companies have change of heart
  9. Highmark lays off nearly 100 workers, mostly in IT, as membership declines
  10. Esmark sues Slovakian businessman for $100M, alleges sabotaged deal
  11. AbbVie to buy leukemia drugmaker Pharmacyclics for $21 billion